Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Greg Zante Insider Profile
4 Followers
Greg Zante, VP, Finance & Administration at Sangamo Biosciences, holds 693.00 shares in Sangamo Biosciences (Ticker: SGMO), holds 207.36K shares in Viking Therapeutics (Ticker: VKTX). Most recently, Greg Zante ― shares of Sangamo Biosciences on ― for an estimated value of ―.
Greg Zante has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Greg Zante holds in companies
Most Profitable Insider Trade
The most profitable trade made by Greg Zante
Greg Zante's Trading History
Sangamo Biosciences
―
VP, Finance & Administration
―
$360.36
Viking Therapeutics
Mar 27, 2024
CFO
Uninformative Sell
1.38M
$13.46M
List of latest transactions for each holding click on a transaction to see Greg Zante's performance on stock
You May Also Like
Greg Zante insider profile FAQ
What is the percentage of profitable transactions made by Greg Zante?
The percentage of profitable transactions made by Greg Zante is ―.
What is the average return per transaction made by Greg Zante?
The average return per transaction made by Greg Zante is ―.
What stocks does Greg Zante hold?
Greg Zante holds: SGMO, VKTX stocks.
What was Greg Zante’s latest transaction?
Greg Zante latest transaction was an Uninformative Buy of ―.
What was Greg Zante's most profitable transaction?
Greg Zante’s most profitable transaction was an Informative Sell of VKTX stock on January 4, 2024. The return on the trade was -241.30%.
What is Greg Zante's role in Sangamo Biosciences?
Greg Zante's role in Sangamo Biosciences is VP, Finance & Administration.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.